| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone-Lysine N-Methyltransferase | 7 | 2021 | 156 | 2.200 |
Why?
|
| Microtubules | 5 | 2021 | 189 | 1.270 |
Why?
|
| Induced Pluripotent Stem Cells | 11 | 2017 | 194 | 1.150 |
Why?
|
| Histone Code | 3 | 2018 | 50 | 1.120 |
Why?
|
| Lysine | 5 | 2020 | 196 | 0.940 |
Why?
|
| DNA Helicases | 1 | 2025 | 231 | 0.860 |
Why?
|
| Tubulin | 3 | 2021 | 103 | 0.830 |
Why?
|
| Pluripotent Stem Cells | 4 | 2017 | 70 | 0.730 |
Why?
|
| Organoids | 2 | 2023 | 281 | 0.710 |
Why?
|
| Mutation, Missense | 1 | 2025 | 875 | 0.690 |
Why?
|
| Cardiomyopathies | 1 | 2025 | 500 | 0.680 |
Why?
|
| Cellular Reprogramming | 3 | 2021 | 105 | 0.670 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2019 | 19 | 0.650 |
Why?
|
| Tissue Engineering | 2 | 2023 | 178 | 0.620 |
Why?
|
| Histones | 7 | 2021 | 523 | 0.620 |
Why?
|
| Methylation | 8 | 2021 | 222 | 0.620 |
Why?
|
| DNA-Binding Proteins | 3 | 2025 | 2047 | 0.590 |
Why?
|
| Cytoskeleton | 3 | 2021 | 185 | 0.570 |
Why?
|
| DNA Methylation | 10 | 2018 | 1008 | 0.550 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2021 | 119 | 0.540 |
Why?
|
| Fibroblasts | 11 | 2021 | 875 | 0.530 |
Why?
|
| Anxiety | 1 | 2021 | 960 | 0.470 |
Why?
|
| Embryonic Stem Cells | 6 | 2015 | 163 | 0.460 |
Why?
|
| Octamer Transcription Factor-3 | 3 | 2015 | 42 | 0.430 |
Why?
|
| Neurons | 3 | 2021 | 1933 | 0.420 |
Why?
|
| Mice | 23 | 2025 | 17625 | 0.420 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 1265 | 0.380 |
Why?
|
| Transcription Factors | 6 | 2019 | 2589 | 0.380 |
Why?
|
| Brain | 3 | 2021 | 2999 | 0.380 |
Why?
|
| Single-Cell Analysis | 3 | 2019 | 277 | 0.360 |
Why?
|
| Animals | 27 | 2025 | 34210 | 0.360 |
Why?
|
| Carcinoma, Renal Cell | 3 | 2018 | 241 | 0.350 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 1034 | 0.350 |
Why?
|
| Rett Syndrome | 1 | 2013 | 291 | 0.340 |
Why?
|
| Cells, Cultured | 11 | 2023 | 3051 | 0.340 |
Why?
|
| Cell Differentiation | 11 | 2017 | 1895 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 9 | 2017 | 1331 | 0.320 |
Why?
|
| RNA, Untranslated | 2 | 2010 | 113 | 0.310 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2021 | 358 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-myc | 3 | 2010 | 196 | 0.300 |
Why?
|
| Kidney Neoplasms | 3 | 2018 | 436 | 0.300 |
Why?
|
| Kruppel-Like Transcription Factors | 2 | 2010 | 108 | 0.300 |
Why?
|
| HMGB Proteins | 1 | 2007 | 9 | 0.290 |
Why?
|
| Cell Line | 5 | 2017 | 2756 | 0.290 |
Why?
|
| Epigenesis, Genetic | 4 | 2018 | 675 | 0.290 |
Why?
|
| Cellular Reprogramming Techniques | 2 | 2018 | 18 | 0.280 |
Why?
|
| Liver Neoplasms | 4 | 2018 | 1292 | 0.280 |
Why?
|
| Endothelial Cells | 3 | 2021 | 522 | 0.280 |
Why?
|
| Mouse Embryonic Stem Cells | 2 | 2018 | 36 | 0.270 |
Why?
|
| Trans-Activators | 2 | 2008 | 797 | 0.260 |
Why?
|
| Homeodomain Proteins | 4 | 2015 | 549 | 0.260 |
Why?
|
| Cell Line, Tumor | 10 | 2020 | 3345 | 0.260 |
Why?
|
| DNA, Neoplasm | 1 | 2007 | 303 | 0.250 |
Why?
|
| Haploinsufficiency | 2 | 2025 | 258 | 0.250 |
Why?
|
| Mitosis | 2 | 2016 | 237 | 0.250 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 2005 | 41 | 0.240 |
Why?
|
| DNA Modification Methylases | 1 | 2005 | 44 | 0.230 |
Why?
|
| Phenotype | 3 | 2025 | 4259 | 0.230 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2008 | 443 | 0.230 |
Why?
|
| Genes, p53 | 1 | 2005 | 212 | 0.220 |
Why?
|
| CpG Islands | 3 | 2017 | 324 | 0.220 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2009 | 1892 | 0.220 |
Why?
|
| SOXB1 Transcription Factors | 3 | 2015 | 58 | 0.210 |
Why?
|
| Humans | 32 | 2025 | 125014 | 0.200 |
Why?
|
| Mesoderm | 3 | 2018 | 110 | 0.200 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 2521 | 0.190 |
Why?
|
| Neural Stem Cells | 2 | 2020 | 119 | 0.180 |
Why?
|
| Hematopoietic Stem Cells | 2 | 2017 | 540 | 0.180 |
Why?
|
| Catalytic Domain | 1 | 2021 | 158 | 0.180 |
Why?
|
| Quinolinic Acid | 1 | 2020 | 10 | 0.170 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2011 | 1290 | 0.170 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2021 | 160 | 0.170 |
Why?
|
| Reading | 1 | 2021 | 79 | 0.170 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 2 | 2017 | 96 | 0.170 |
Why?
|
| GTP-Binding Proteins | 1 | 2020 | 179 | 0.170 |
Why?
|
| Neoplasm Metastasis | 2 | 2015 | 685 | 0.160 |
Why?
|
| Carcinoma, Hepatocellular | 3 | 2018 | 920 | 0.160 |
Why?
|
| Regeneration | 1 | 2021 | 212 | 0.160 |
Why?
|
| Huntington Disease | 1 | 2020 | 143 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2019 | 142 | 0.150 |
Why?
|
| Neural Plate | 1 | 2018 | 11 | 0.150 |
Why?
|
| Genomic Instability | 2 | 2018 | 229 | 0.150 |
Why?
|
| Chimera | 1 | 2018 | 83 | 0.150 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2018 | 49 | 0.150 |
Why?
|
| Actins | 1 | 2020 | 346 | 0.150 |
Why?
|
| Primary Cell Culture | 1 | 2018 | 101 | 0.150 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2018 | 11 | 0.150 |
Why?
|
| Gene Knockout Techniques | 1 | 2018 | 124 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2018 | 95 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2017 | 1707 | 0.140 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2008 | 54 | 0.140 |
Why?
|
| HEK293 Cells | 2 | 2018 | 736 | 0.140 |
Why?
|
| Mad2 Proteins | 1 | 2017 | 9 | 0.140 |
Why?
|
| Hepatocyte Nuclear Factor 1-beta | 1 | 2017 | 29 | 0.140 |
Why?
|
| Ischemia | 2 | 2017 | 362 | 0.140 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2017 | 97 | 0.140 |
Why?
|
| Nanostructures | 1 | 2017 | 50 | 0.140 |
Why?
|
| Oligopeptides | 1 | 2017 | 118 | 0.140 |
Why?
|
| Disease Models, Animal | 2 | 2025 | 4390 | 0.140 |
Why?
|
| Liver | 2 | 2023 | 1743 | 0.140 |
Why?
|
| Blotting, Western | 5 | 2015 | 1103 | 0.130 |
Why?
|
| Heart | 1 | 2021 | 728 | 0.130 |
Why?
|
| beta Catenin | 1 | 2018 | 203 | 0.130 |
Why?
|
| Cytokinesis | 1 | 2016 | 28 | 0.130 |
Why?
|
| Nanog Homeobox Protein | 3 | 2015 | 29 | 0.130 |
Why?
|
| Hepatitis B virus | 2 | 2008 | 130 | 0.120 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2018 | 359 | 0.120 |
Why?
|
| Antibodies | 1 | 2016 | 375 | 0.120 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1399 | 0.120 |
Why?
|
| DNA | 4 | 2011 | 1608 | 0.110 |
Why?
|
| Gene Transfer Techniques | 2 | 2009 | 354 | 0.110 |
Why?
|
| Myocardial Infarction | 1 | 2021 | 1039 | 0.110 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2013 | 309 | 0.110 |
Why?
|
| Cell Cycle Proteins | 1 | 2017 | 656 | 0.100 |
Why?
|
| Receptor, Notch1 | 1 | 2013 | 64 | 0.100 |
Why?
|
| Cell Nucleus | 2 | 2009 | 680 | 0.100 |
Why?
|
| Repressor Proteins | 2 | 2015 | 815 | 0.100 |
Why?
|
| Williams Syndrome | 1 | 2012 | 40 | 0.100 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2012 | 20 | 0.100 |
Why?
|
| bcl-X Protein | 1 | 2011 | 31 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 238 | 0.090 |
Why?
|
| Male | 9 | 2025 | 61429 | 0.090 |
Why?
|
| Embryo, Mammalian | 3 | 2017 | 460 | 0.090 |
Why?
|
| Adrenoleukodystrophy | 1 | 2011 | 8 | 0.090 |
Why?
|
| Base Sequence | 5 | 2009 | 3102 | 0.090 |
Why?
|
| Hematopoiesis | 1 | 2013 | 216 | 0.090 |
Why?
|
| Growth | 1 | 2011 | 106 | 0.090 |
Why?
|
| Hematopoietic System | 1 | 2010 | 7 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 388 | 0.090 |
Why?
|
| Viral Regulatory and Accessory Proteins | 2 | 2008 | 37 | 0.090 |
Why?
|
| Bone Marrow Cells | 2 | 2010 | 264 | 0.090 |
Why?
|
| Sulfites | 2 | 2009 | 30 | 0.090 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 527 | 0.080 |
Why?
|
| Tristetraprolin | 1 | 2009 | 6 | 0.080 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2009 | 138 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 129 | 0.080 |
Why?
|
| Proteome | 1 | 2011 | 243 | 0.080 |
Why?
|
| Signal Transduction | 5 | 2015 | 4531 | 0.080 |
Why?
|
| Transcription, Genetic | 3 | 2010 | 1701 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2009 | 177 | 0.070 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 109 | 0.070 |
Why?
|
| Neovascularization, Physiologic | 2 | 2021 | 214 | 0.070 |
Why?
|
| Karyotyping | 1 | 2008 | 323 | 0.070 |
Why?
|
| Female | 6 | 2025 | 66709 | 0.070 |
Why?
|
| Cell Shape | 1 | 2007 | 61 | 0.070 |
Why?
|
| RNA-Binding Proteins | 1 | 2011 | 573 | 0.070 |
Why?
|
| Molecular Sequence Data | 5 | 2015 | 3892 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2021 | 4403 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2008 | 204 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 255 | 0.070 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2007 | 24 | 0.070 |
Why?
|
| Hindlimb | 2 | 2017 | 80 | 0.070 |
Why?
|
| Blotting, Southern | 1 | 2007 | 215 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 314 | 0.070 |
Why?
|
| Teratoma | 1 | 2007 | 120 | 0.070 |
Why?
|
| Metabolome | 1 | 2009 | 293 | 0.070 |
Why?
|
| Deoxyribonucleotides | 1 | 2006 | 10 | 0.070 |
Why?
|
| Peptides | 1 | 2009 | 811 | 0.060 |
Why?
|
| Mice, Nude | 2 | 2017 | 708 | 0.060 |
Why?
|
| Transcription Factor HES-1 | 2 | 2017 | 17 | 0.060 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2008 | 468 | 0.060 |
Why?
|
| Protein Binding | 3 | 2021 | 1757 | 0.060 |
Why?
|
| Micromonospora | 1 | 2004 | 2 | 0.060 |
Why?
|
| Naphthoquinones | 1 | 2004 | 8 | 0.060 |
Why?
|
| Fetus | 1 | 2007 | 584 | 0.060 |
Why?
|
| DNA Primers | 1 | 2005 | 657 | 0.050 |
Why?
|
| Transfection | 3 | 2010 | 1068 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 359 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2015 | 3741 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2009 | 1758 | 0.050 |
Why?
|
| Histone Deacetylase 1 | 2 | 2015 | 21 | 0.050 |
Why?
|
| Cell Proliferation | 3 | 2017 | 2308 | 0.050 |
Why?
|
| RNA, Long Noncoding | 1 | 2005 | 213 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 1583 | 0.050 |
Why?
|
| Cattle | 2 | 2000 | 569 | 0.050 |
Why?
|
| Hepatocytes | 1 | 2023 | 208 | 0.050 |
Why?
|
| Mutation | 2 | 2021 | 5846 | 0.050 |
Why?
|
| Cell Cycle | 2 | 2017 | 618 | 0.050 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2021 | 38 | 0.050 |
Why?
|
| Gap Junctions | 1 | 2021 | 38 | 0.050 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 235 | 0.050 |
Why?
|
| Myosin Heavy Chains | 1 | 2021 | 77 | 0.050 |
Why?
|
| Ascorbic Acid | 1 | 2021 | 78 | 0.050 |
Why?
|
| COS Cells | 1 | 2021 | 275 | 0.040 |
Why?
|
| Virus Replication | 1 | 2004 | 608 | 0.040 |
Why?
|
| Freezing | 1 | 2000 | 28 | 0.040 |
Why?
|
| Disease Progression | 1 | 2007 | 2061 | 0.040 |
Why?
|
| Blastocyst | 1 | 2000 | 75 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2011 | 399 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2000 | 312 | 0.040 |
Why?
|
| Alcohol Oxidoreductases | 1 | 1999 | 20 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 272 | 0.040 |
Why?
|
| Pseudogenes | 1 | 1999 | 53 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2015 | 1006 | 0.040 |
Why?
|
| Lactoferrin | 1 | 1999 | 78 | 0.040 |
Why?
|
| RNA, Small Interfering | 2 | 2013 | 663 | 0.040 |
Why?
|
| Apoptosis | 2 | 2017 | 1803 | 0.040 |
Why?
|
| Milk | 1 | 1999 | 119 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 2717 | 0.040 |
Why?
|
| Micronuclei, Chromosome-Defective | 1 | 2018 | 9 | 0.040 |
Why?
|
| Oocytes | 1 | 2000 | 297 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2017 | 1501 | 0.040 |
Why?
|
| Chromatin | 1 | 2021 | 554 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 1 | 2017 | 121 | 0.040 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2018 | 107 | 0.030 |
Why?
|
| Chromosomal Instability | 1 | 2017 | 57 | 0.030 |
Why?
|
| K562 Cells | 1 | 2017 | 95 | 0.030 |
Why?
|
| Erythropoiesis | 1 | 2017 | 39 | 0.030 |
Why?
|
| Aneuploidy | 1 | 2017 | 152 | 0.030 |
Why?
|
| Random Allocation | 1 | 2017 | 440 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2008 | 131 | 0.030 |
Why?
|
| Myocardium | 1 | 2021 | 1016 | 0.030 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2017 | 164 | 0.030 |
Why?
|
| Histone Deacetylase 2 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Trypsin | 1 | 2015 | 96 | 0.030 |
Why?
|
| Endoderm | 1 | 2015 | 23 | 0.030 |
Why?
|
| Ectoderm | 1 | 2015 | 31 | 0.030 |
Why?
|
| Activins | 1 | 2015 | 73 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2015 | 69 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2017 | 410 | 0.030 |
Why?
|
| Acetylation | 1 | 2015 | 163 | 0.030 |
Why?
|
| Cell Lineage | 1 | 2017 | 345 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2018 | 334 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 951 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2007 | 8194 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2021 | 835 | 0.030 |
Why?
|
| Autophagy | 1 | 2018 | 392 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 2017 | 1080 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 369 | 0.030 |
Why?
|
| RNA, Messenger | 2 | 2011 | 2821 | 0.030 |
Why?
|
| Dermis | 1 | 2013 | 24 | 0.030 |
Why?
|
| Anemia | 1 | 2017 | 340 | 0.030 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 258 | 0.030 |
Why?
|
| Biomarkers | 2 | 2013 | 3079 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2015 | 458 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 2424 | 0.030 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2011 | 5 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2011 | 31 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 881 | 0.020 |
Why?
|
| Clonal Evolution | 1 | 2011 | 40 | 0.020 |
Why?
|
| Lovastatin | 1 | 2011 | 27 | 0.020 |
Why?
|
| Adult | 2 | 2012 | 29620 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2013 | 201 | 0.020 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2011 | 136 | 0.020 |
Why?
|
| Iduronidase | 1 | 2010 | 2 | 0.020 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2010 | 7 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2011 | 154 | 0.020 |
Why?
|
| Phenylbutyrates | 1 | 2011 | 58 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2013 | 794 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2011 | 76 | 0.020 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2011 | 130 | 0.020 |
Why?
|
| Keratinocytes | 1 | 2010 | 62 | 0.020 |
Why?
|
| Embryo Transfer | 2 | 2000 | 58 | 0.020 |
Why?
|
| Genome, Human | 1 | 2017 | 1274 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2011 | 229 | 0.020 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 190 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2010 | 211 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2011 | 196 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2013 | 1016 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 846 | 0.020 |
Why?
|
| Endosomes | 1 | 2009 | 64 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2009 | 80 | 0.020 |
Why?
|
| RNA Stability | 1 | 2009 | 84 | 0.020 |
Why?
|
| Fertilization in Vitro | 2 | 2000 | 147 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2010 | 302 | 0.020 |
Why?
|
| Polymers | 1 | 2009 | 104 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2009 | 235 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2010 | 339 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 306 | 0.020 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 209 | 0.020 |
Why?
|
| Plasmids | 1 | 2009 | 513 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 1695 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 766 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 1303 | 0.020 |
Why?
|
| Electrophoresis, Capillary | 1 | 2006 | 12 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2009 | 546 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 618 | 0.020 |
Why?
|
| Cytosine | 1 | 2006 | 56 | 0.020 |
Why?
|
| Hydrolysis | 1 | 2006 | 161 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2015 | 4811 | 0.020 |
Why?
|
| Genotype | 1 | 2011 | 2561 | 0.020 |
Why?
|
| Reference Standards | 1 | 2006 | 236 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2008 | 1694 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 732 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2004 | 158 | 0.010 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2004 | 115 | 0.010 |
Why?
|
| Molecular Structure | 1 | 2004 | 295 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2011 | 1200 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2633 | 0.010 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2004 | 296 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2004 | 347 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12383 | 0.010 |
Why?
|
| Microinjections | 1 | 2000 | 52 | 0.010 |
Why?
|
| Cell Fusion | 1 | 2000 | 37 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2000 | 137 | 0.010 |
Why?
|
| Cryopreservation | 1 | 2000 | 73 | 0.010 |
Why?
|
| Coculture Techniques | 1 | 2000 | 226 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 2000 | 326 | 0.010 |
Why?
|
| Time Factors | 1 | 2009 | 6326 | 0.010 |
Why?
|
| Caseins | 1 | 1999 | 64 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1999 | 261 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1999 | 462 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1999 | 429 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1999 | 897 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 824 | 0.010 |
Why?
|
| Swine | 1 | 2000 | 1207 | 0.010 |
Why?
|
| Models, Genetic | 1 | 1999 | 760 | 0.010 |
Why?
|
| Mammary Glands, Animal | 1 | 1999 | 481 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1999 | 937 | 0.010 |
Why?
|
| Infant | 1 | 2010 | 12458 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 13978 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 1999 | 2397 | 0.010 |
Why?
|
| Child | 1 | 2012 | 24339 | 0.010 |
Why?
|